How does Rhopressa work?
Medically reviewed by Drugs.com. Last updated on Jan 2, 2024.
Rhopressa reduces intraocular pressure (IOP) by increasing outflow of aqueous humor (the fluid inside the eye) through the trabecular meshwork, the main fluid drain of the eye.
Rhopressa (netarsudil ophthalmic solution) 0.02%, from Aerie Pharmaceuticals, is a Rho Kinase Inhibitor. Rhopressa, a once daily eye drop for lowering IOP in patients with open-angle glaucoma or ocular hypertension, was FDA-approved in December 2017.
Drug information
- Rhopressa Information for Consumers
- Rhopressa prescribing info & package insert (for Health Professionals)
- Side Effects of Rhopressa (detailed)
Related support groups
- Rhopressa (1 questions, 3 members)
- Glaucoma (Open Angle) (11 questions, 51 members)
- Intraocular Hypertension (8 questions, 24 members)
